US5331958A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Spectrophotometric blood analysis
Assignee: Coretech Medical Technologies Corp
•
Filing: 1993-03-25
•
Granted: 1994-07-26
•
Expires: 2013-03-25
Abstract
Abstract A method and device are described which are particularly useful for continuous on-line monitoring of hematocrit and other blood parameters. The effect of change in blood electrolyte composition, for example, in blood sodium concentration, is taken into consideration. This effect has been found to change light beam geometry, and is taken advantage of to provide for blood sodium concentration measurement. The devices may be applied to extracorporeal circuits or to body parts capable of being transilluminated. The devices may be used to optimize dialysis, and also for monitoring optically detectable, exogenous macromolecules.
Inventors
- 👤 Luis Oppenheimer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 12:14
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/14535; A61B5/1455; A61B5/14551; A61B5/14557; A61M; A61M1/00; A61M1/36; A61M1/3607; A61M1/3609; G; G01; G01N; G01N21/00; G01N21/17; G01N21/47; G01N21/49; G01N21/53; G01N21/532; G01N15/00; G01N15/04; G01N15/05; G01N2015/055; G01N21/01; G01N21/03; G01N2021/0364; G01N21/25; G01N21/31; G01N21/314; G01N2021/3144
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
44 words
A method for optically determining blood parameters, said method comprising directing a light beam into a patient's blood, detecting and measuring the light emerging from the blood, and compensating for any change in light beam geometry induced by any change in blood electrolyte composition.
Claim 2
Independent Claim
44 words
A method for optically determining blood parameters, said method comprising directing a light beam into a patient's blood, detecting and measuring the light emerging from the blood, and compensating for any change in light beam geometry induced by any change in blood electrolyte composition.
Claim 3
Dependent Claim
15 words
The method of claim 1, wherein blood concentration of endogenous, optically detectable macromolecules is determined.
Claim 4
Dependent Claim
20 words
The method of claim 1, comprising eliminating the effect of blood oxygen saturation on said determination, wherein hematocrit is determined.
Claim 5
Dependent Claim
11 words
The method of claim 3, wherein an isobestic wavelength is selected.
Claim 6
Dependent Claim
28 words
The method of claim 1, further comprising directing into the blood, light of a wavelength selected to detect optically detectable macromolecules, and detecting emerging light of said wavelength.
Claim 7
Dependent Claim
10 words
The method of claim 1, wherein said electrolyte is sodium.
Claim 8
Dependent Claim
18 words
The method of claim 1, wherein said light beam is directed into an extracorporeal circuit containing flowing blood.
Claim 9
Dependent Claim
16 words
The method of claim 7, comprising returning the blood to the patient after said detecting step.
Claim 10
Dependent Claim
18 words
The method of claim 1, wherein detected changes in fluid balance are monitored to achieve fluid level management.
Claim 11
Dependent Claim
22 words
The method of claim 9, wherein in conjunction with said monitoring to achieve fluid level management, rate of fluid removal is regulated.
Claim 12
Dependent Claim
23 words
The method of claim 10, further comprising administering to the patient, a suitable therapeutic agent in an amount sufficient to assist fluid removal.
Claim 13
Dependent Claim
11 words
The method of claim 1, wherein blood oxygen content is determined.
Claim 14
Dependent Claim
28 words
The method of claim 1, comprising prior to said light detecting step, determining light beam geometry and selecting detectors located for sensitivity to change in light beam geometry.
Claim 15
Independent Claim
119 words
A method for optically determining the blood concentration of macromolecules useful in evaluating exchange properties of blood vessels of a patient, comprising adding to the blood of the patient, a macromolecular mixture comprising a first macromolecular component characterized by a first vascular transport-affecting property and a first optically detectable property, and a second macromolecular component characterized by a second vascular transport-affecting property and a second optically detectable property, wherein said first and second transport-affecting properties differently affect transvascular transport, and wherein said first optically detectable property is optically distinct from said second optically detectable property; and optically detecting change in blood concentration of at least one component of said macromolecular mixture, using a wavelength appropriate for each component determined.
Claim 16
Independent Claim
119 words
A method for optically determining the blood concentration of macromolecules useful in evaluating exchange properties of blood vessels of a patient, comprising adding to the blood of the patient, a macromolecular mixture comprising a first macromolecular component characterized by a first vascular transport-affecting property and a first optically detectable property, and a second macromolecular component characterized by a second vascular transport-affecting property and a second optically detectable property, wherein said first and second transport-affecting properties differently affect transvascular transport, and wherein said first optically detectable property is optically distinct from said second optically detectable property; and optically detecting change in blood concentration of at least one component of said macromolecular mixture, using a wavelength appropriate for each component determined.
Claim 17
Dependent Claim
56 words
The method of claim 14, wherein change in blood concentration of said first macromolecular component and of said second macromolecular component of said macromolecular mixture is optically detected, using a first wavelength appropriate for said first optically detectable property, and a second wavelength distinct from said first wavelength and appropriate for said second optically detectable property.
Claim 18
Dependent Claim
22 words
The method of claim 14, wherein said transvascular transport-affecting properties are selected from the group consisting of molecular weight, charge and rigidity.
Claim 19
Independent Claim
53 words
A method for optically determining blood sodium concentration, said method comprising directing a light beam into a patient's blood, detecting and measuring the light emerging from the blood, and evaluating any change in scatter of said light beam by comparison to a sodium reference, whereby an absolute blood sodium concentration may be obtained.
Claim 20
Independent Claim
53 words
A method for optically determining blood sodium concentration, said method comprising directing a light beam into a patient's blood, detecting and measuring the light emerging from the blood, and evaluating any change in scatter of said light beam by comparison to a sodium reference, whereby an absolute blood sodium concentration may be obtained.
Claim 21
Independent Claim
84 words
A device for optically determining blood parameters, said device comprising means for generating a light beam suitable for being directed into a patient's blood; first detecting means and second detecting means each disposed at a suitable location to be sensitive to any change in scatter of said light beam, but differently disposed with respect to said light beam; sodium concentration reference means; and signal evaluation means in operative communication with said first detecting means, said second detecting means, and said sodium concentration reference means.
Claim 22
Independent Claim
84 words
A device for optically determining blood parameters, said device comprising means for generating a light beam suitable for being directed into a patient's blood; first detecting means and second detecting means each disposed at a suitable location to be sensitive to any change in scatter of said light beam, but differently disposed with respect to said light beam; sodium concentration reference means; and signal evaluation means in operative communication with said first detecting means, said second detecting means, and said sodium concentration reference means.
Claim 23
Dependent Claim
31 words
The device of claim 18, wherein said detecting means are light detecting means, and wherein said location for said first detecting means provides for directly emerging light to be predominantly detected.
Claim 24
Dependent Claim
13 words
The device of claim 18, wherein a constant light path length is provided.
Claim 25
Dependent Claim
17 words
The device of claim 18, wherein said means for generating a light beam, emits an isobestic wavelength.
References Cited (Backward Citations)
US3830569A
Cited
US4303336A
Cited
US4243883A
Cited
US4515165A
Cited
US4484135A
Cited
US4745279A
Cited
US5190040A
Cited
US4776340A
Cited
US5149503A
Cited
US4819752A
Cited
US5048524A
Cited
US5195963A
Cited
USH1114H
Cited
US5066859A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-07-25 | 1998-01-24 | 1998-07-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-07-25 | 2002-01-24 | 2002-07-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-07-25 | 2006-01-24 | 2006-07-26 | $7700.00 | Window Closed / Lapsed |